Tag «company content»

Thomson Reuters Names 2014 Drugs to Watch

Analysis points to three potential blockbusters: Sovaldi, Anoro Ellipta and Idelalisib entering market this year 04/23/2014 PHILADELPHIA – The Intellectual Property & Science business of Thomson Reuters, the world’s leading provider of intelligent information for businesses and professionals, released its annual forecast of the leading drugs to watch in 2014, including three potential blockbuster treatments …